Find News

Filter articles

Showing 3301 to 3310 of 3632 results

Occlutech defeats AGA in “hole in heart” patent case


German medical device company Occlutech has successfully defeated US-based AGA Medical Corporation after the English High Court declared a patent AGA was trying to assert invalid.

Janssen and Grünenthal sue Watson over Nucynta generic

US24-07-2014Legal developments

Johnson & Johnson’s pharmaceutical subsidiary Janssen and Germany-based pharmaceutical company Grünenthal have sued Watson Laboratories for infringing patents related to painkiller Nucynta (tapentadol hydrochloride).

Patent expiries take chunk out of Lilly’s profits


A 17 percent fall in Eli Lilly’s second-quarter revenue to $4.94 billion, reported today (July 24), was driven by the expiry of US patents covering antidepressant Cymbalta (duloxetine hydrochloride) and osteoporosis drug Evista (raloxifene hydrochloride), the company said.

Court denies Lilly’s application to block GSK SPC

US23-07-2014Legal developments

The English High Court has dismissed an application by Eli Lilly to stop Human Genome Sciences from getting an SPC based on a marketing authorisation Lilly may receive for a new drug.

Steptoe & Johnson adds litigator in New York


Steptoe & Johnson LLP has added to its IP team with the appointment of patent litigator John Molenda.

Mylan lands injunction against GSK’s Paroxetine

US22-07-2014Legal developments

The US District Court for the District of New Jersey has granted Mylan its motion for a permanent injunction against GlaxoSmithKline’s (GSK’s) Paroxetine CR.

CJEU opinion on embryos builds on Brüstle decision

EU, UK21-07-2014Legal developments

The Attorney General for the Court of Justice of the European Union has issued an opinion on the meaning of the term ‘human embryos’ that could "significantly restrict" the scope of the Brüstle decision of 2011.

MPP signs licences to increase access to HIV drugs


The Medicines Patent Pool (MPP) has announced seven new sub-licensing agreements to make generic HIV medicines atazanavir (ATV) and dolutegravir (DTG).

Alcon responds to Aurobindo’s proposed Vigamox generic

US17-07-2014Legal developments

Novartis’s eye care unit Alcon Pharmaceuticals has sued Hyderabad-based Aurobindo Pharma for infringing two patents covering its eye drop solution Vigamox (moxifloxacin hydrochloride) at the US District Court for the District of Delaware.

English High Court refuses to stay Pharmacia patent revocation case

UK17-07-2014Legal developments

The England and Wales High Court has refused Pfizer subsidiary Pharmacia’s request to stay Actavis’s patent revocation action against it.

Showing 3301 to 3310 of 3632 results